drugset
drugset / Trial / NCT00688493

Effects of Single Oral Dose Dapagliflozin QT Study

NCT00688493 ↗

Phase 1 Completed 36 enrolled AstraZeneca Bristol-Myers Squibb · collab
RandomizedCrossoverDouble-blindBasic science

Summary

The main purpose of this study is to examine the effect of dapagliflozin on electronic measures of heart beats in healthy males

Timeline

Start
2007-07
Primary completion
—
Completion
2008-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Dapagliflozin Small molecule 20 mg Oral
Subject Dapagliflozin Small molecule 150 mg Oral
Subject Moxifloxacin Small molecule 400 mg Oral

Indications

No indication recorded.